cellular process (GO:0009987) | 0.26 | 10 | CLN6, CLN8, PPT1, CTSD, TPP1, SMPD1, MFSD8, CLN3, CLN5, DNAJC5 |
single-organism process (GO:0044699) | 0.48 | 10 | GRN, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5, DNAJC5 |
organic substance metabolic process (GO:0071704) | 0.63 | 9 | CTSF, CLN6, CLN8, PPT1, CTSD, TPP1, SMPD1, CLN3, CLN5 |
biological regulation (GO:0065007) | 0.39 | 9 | GRN, CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5, CLN5 |
metabolic process (GO:0008152) | 0.58 | 9 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
primary metabolic process (GO:0044238) | 0.69 | 9 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
single-organism metabolic process (GO:0044710) | 1.63 | 8 | CLN6, CLN8, TPP1, CTSD, PPT1, SMPD1, CLN3, CLN5 |
protein metabolic process (GO:0019538) | 1.45 | 8 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
organic substance catabolic process (GO:1901575) | 2.45 | 8 | CLN3, CLN6, CLN8, TPP1, SMPD1, PPT1, CTSD, CLN5 |
regulation of cellular process (GO:0050794) | 0.5 | 8 | CLN6, GRN, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5 |
single-organism cellular process (GO:0044763) | 0.65 | 8 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5, DNAJC5 |
macromolecule metabolic process (GO:0043170) | 0.83 | 8 | CTSF, CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
catabolic process (GO:0009056) | 2.38 | 8 | CLN3, CLN6, CLN8, TPP1, SMPD1, PPT1, CTSD, CLN5 |
regulation of biological process (GO:0050789) | 0.45 | 8 | CLN6, GRN, CLN8, TPP1, CLN3, PPT1, SMPD1, DNAJC5 |
organelle organization (GO:0006996) | 2.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
vacuole organization (GO:0007033) | 4.67 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
multicellular organismal process (GO:0032501) | 1.45 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
organonitrogen compound metabolic process (GO:1901564) | 2.32 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5 |
cellular metabolic process (GO:0044237) | 0.69 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, SMPD1, CLN5 |
cellular component organization (GO:0016043) | 1.24 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 7 | CLN6, CLN8, TPP1, SMPD1, PPT1, CLN3, CLN5 |
protein catabolic process (GO:0030163) | 3.93 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
lysosome organization (GO:0007040) | 6.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
regulation of biological quality (GO:0065008) | 1.68 | 7 | CLN6, CLN8, PPT1, CLN3, TPP1, DNAJC5, CLN5 |
macromolecule catabolic process (GO:0009057) | 3.0 | 7 | CLN6, CLN8, TPP1, CTSD, PPT1, CLN3, CLN5 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
lytic vacuole organization (GO:0080171) | 6.02 | 7 | CLN6, CLN8, TPP1, CLN3, PPT1, MFSD8, CLN5 |
lipid metabolic process (GO:0006629) | 2.68 | 6 | CLN6, CLN8, TPP1, SMPD1, PPT1, CLN3 |
cellular amide metabolic process (GO:0043603) | 3.23 | 6 | CLN6, CLN8, SMPD1, TPP1, CLN3, CLN5 |
neurological system process (GO:0050877) | 2.64 | 6 | CLN6, CLN8, TPP1, CLN3, PPT1, CLN5 |
transport (GO:0006810) | 1.51 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 6 | CLN6, CLN8, SMPD1, TPP1, CLN3, CLN5 |
establishment of localization (GO:0051234) | 1.48 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
localization (GO:0051179) | 1.4 | 6 | GRN, CLN8, CLN3, PPT1, MFSD8, DNAJC5 |
system process (GO:0003008) | 2.3 | 6 | CLN6, CLN8, TPP1, CLN3, PPT1, CLN5 |
developmental process (GO:0032502) | 1.36 | 5 | CLN8, PPT1, TPP1, CLN5, SMPD1 |
cellular catabolic process (GO:0044248) | 2.62 | 5 | CLN8, PPT1, CLN6, TPP1, SMPD1 |
membrane lipid metabolic process (GO:0006643) | 4.51 | 5 | CLN8, PPT1, SMPD1, CLN6, CLN3 |
establishment of localization in cell (GO:0051649) | 2.47 | 5 | CLN8, PPT1, CLN3, DNAJC5, GRN |
response to stimulus (GO:0050896) | 1.22 | 5 | CLN8, PPT1, SMPD1, TPP1, GRN |
anatomical structure development (GO:0048856) | 1.58 | 5 | CLN8, PPT1, TPP1, CLN5, SMPD1 |
homeostatic process (GO:0042592) | 2.61 | 5 | PPT1, CLN5, TPP1, CLN3, CLN6 |
regulation of programmed cell death (GO:0043067) | 2.49 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
proteolysis (GO:0006508) | 2.73 | 5 | TPP1, CLN3, CLN5, CTSD, CTSF |
negative regulation of biological process (GO:0048519) | 1.33 | 5 | CLN8, PPT1, CLN3, DNAJC5, SMPD1 |
cellular lipid metabolic process (GO:0044255) | 2.92 | 5 | CLN8, PPT1, SMPD1, CLN3, CLN6 |
regulation of cell death (GO:0010941) | 2.43 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
regulation of apoptotic process (GO:0042981) | 2.5 | 5 | CLN8, PPT1, CLN3, DNAJC5, SMPD1 |
sphingolipid metabolic process (GO:0006665) | 4.79 | 5 | PPT1, CLN8, CLN3, SMPD1, CLN6 |
negative regulation of cellular process (GO:0048523) | 1.41 | 5 | CLN8, PPT1, SMPD1, DNAJC5, CLN3 |
regulation of lysosomal lumen pH (GO:0035751) | 7.65 | 4 | PPT1, CLN5, CLN3, CLN6 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | CLN8, SMPD1, CLN3, CLN6 |
regulation of metabolic process (GO:0019222) | 1.02 | 4 | CLN8, SMPD1, CLN3, CLN6 |
ion homeostasis (GO:0050801) | 3.42 | 4 | PPT1, CLN6, CLN5, CLN3 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | CLN8, SMPD1, CLN3, CLN6 |
behavior (GO:0007610) | 3.47 | 4 | CLN8, PPT1, CLN3, GRN |
inorganic ion homeostasis (GO:0098771) | 3.43 | 4 | PPT1, CLN5, CLN3, CLN6 |
signal transduction (GO:0007165) | 1.28 | 4 | TPP1, CLN3, SMPD1, GRN |
regulation of intracellular pH (GO:0051453) | 5.44 | 4 | PPT1, CLN5, CLN3, CLN6 |
intracellular pH reduction (GO:0051452) | 6.09 | 4 | PPT1, CLN6, CLN5, CLN3 |
regulation of cellular pH (GO:0030641) | 5.41 | 4 | PPT1, CLN6, CLN5, CLN3 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 4 | CLN8, PPT1, CLN5, CLN6 |
regulation of pH (GO:0006885) | 5.24 | 4 | PPT1, CLN6, CLN5, CLN3 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 4 | CLN8, SMPD1, CLN3, CLN6 |
negative regulation of apoptotic process (GO:0043066) | 3.04 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
positive regulation of biological process (GO:0048518) | 1.2 | 4 | PPT1, SMPD1, CLN6, GRN |
regulation of neurotransmitter levels (GO:0001505) | 4.77 | 4 | CLN8, PPT1, DNAJC5, CLN3 |
cellular homeostasis (GO:0019725) | 3.23 | 4 | PPT1, CLN5, CLN3, CLN6 |
pH reduction (GO:0045851) | 6.07 | 4 | PPT1, CLN6, CLN5, CLN3 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 4 | CLN8, SMPD1, CLN3, CLN6 |
negative regulation of cell death (GO:0060548) | 2.95 | 4 | CLN8, DNAJC5, PPT1, CLN3 |
visual perception (GO:0007601) | 4.41 | 4 | CLN8, CLN5, PPT1, CLN6 |
sensory perception (GO:0007600) | 2.93 | 4 | CLN8, PPT1, CLN5, CLN6 |
cellular ion homeostasis (GO:0006873) | 3.57 | 4 | PPT1, CLN6, CLN5, CLN3 |
sensory perception of light stimulus (GO:0050953) | 4.4 | 4 | CLN8, PPT1, CLN5, CLN6 |
cellular monovalent inorganic cation homeostasis (GO:0030004) | 5.19 | 4 | PPT1, CLN5, CLN3, CLN6 |
single-organism transport (GO:0044765) | 2.18 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 4 | PPT1, CLN5, CLN3, CLN6 |
cellular cation homeostasis (GO:0030003) | 3.6 | 4 | PPT1, CLN6, CLN5, CLN3 |
cation homeostasis (GO:0055080) | 3.46 | 4 | PPT1, CLN5, CLN3, CLN6 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 4 | PPT1, CLN5, CLN3, CLN6 |
single-organism localization (GO:1902578) | 2.09 | 4 | PPT1, DNAJC5, CLN8, CLN3 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 4 | CLN8, CLN6, SMPD1, CLN3 |
vesicle-mediated transport (GO:0016192) | 2.72 | 4 | PPT1, DNAJC5, CLN3, GRN |
single-multicellular organism process (GO:0044707) | 1.78 | 4 | CLN8, PPT1, CLN3, CTSD |
vacuolar acidification (GO:0007035) | 7.02 | 4 | PPT1, CLN5, CLN3, CLN6 |
negative regulation of programmed cell death (GO:0043069) | 3.02 | 4 | CLN8, PPT1, DNAJC5, CLN3 |
nervous system development (GO:0007399) | 3.53 | 4 | CLN8, PPT1, TPP1, SMPD1 |
chemical homeostasis (GO:0048878) | 2.97 | 4 | PPT1, CLN6, CLN5, CLN3 |
cellular developmental process (GO:0048869) | 1.82 | 4 | CLN8, PPT1, TPP1, CLN5 |
system development (GO:0048731) | 2.92 | 4 | CLN8, TPP1, PPT1, SMPD1 |
positive regulation of cellular process (GO:0048522) | 1.3 | 4 | PPT1, SMPD1, CLN6, GRN |
ceramide metabolic process (GO:0006672) | 5.41 | 4 | CLN8, CLN6, CLN3, SMPD1 |
lysosomal lumen acidification (GO:0007042) | 8.12 | 4 | PPT1, CLN5, CLN3, CLN6 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | CLN8, SMPD1, CLN3 |
cell differentiation (GO:0030154) | 2.14 | 3 | CLN8, TPP1, CLN5 |
learning (GO:0007612) | 4.85 | 3 | PPT1, CLN8, CLN3 |
learning or memory (GO:0007611) | 4.33 | 3 | PPT1, CLN8, CLN3 |
cellular biosynthetic process (GO:0044249) | 1.37 | 3 | PPT1, CLN8, SMPD1 |
regulation of neuron apoptotic process (GO:0043523) | 4.47 | 3 | PPT1, DNAJC5, CLN3 |
negative regulation of neuron apoptotic process (GO:0043524) | 4.82 | 3 | PPT1, DNAJC5, CLN3 |
small molecule metabolic process (GO:0044281) | 2.38 | 3 | CLN8, CLN3, CLN6 |
neuromuscular process (GO:0050905) | 5.27 | 3 | TPP1, CLN8, CLN3 |
single-organism catabolic process (GO:0044712) | 3.21 | 3 | PPT1, SMPD1, CTSD |
cellular protein metabolic process (GO:0044267) | 1.63 | 3 | CLN8, PPT1, CLN5 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 3 | CLN8, SMPD1, CLN3 |
cellular macromolecule catabolic process (GO:0044265) | 3.19 | 3 | PPT1, CLN8, CLN6 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | CLN8, CLN3, SMPD1 |
neuromuscular process controlling balance (GO:0050885) | 5.88 | 3 | TPP1, CLN8, CLN3 |
glycosphingolipid metabolic process (GO:0006687) | 5.49 | 3 | SMPD1, CLN3, CLN6 |
organic substance transport (GO:0071702) | 2.15 | 3 | PPT1, CLN8, CLN3 |
regulation of molecular function (GO:0065009) | 1.78 | 3 | PPT1, CLN3, SMPD1 |
glycolipid metabolic process (GO:0006664) | 5.01 | 3 | CLN3, SMPD1, CLN6 |
liposaccharide metabolic process (GO:1903509) | 4.98 | 3 | CLN3, SMPD1, CLN6 |
phospholipid metabolic process (GO:0006644) | 3.88 | 3 | CLN8, SMPD1, CLN3 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 3 | CLN8, CLN3, SMPD1 |
organic substance biosynthetic process (GO:1901576) | 1.34 | 3 | PPT1, CLN8, SMPD1 |
regulation of catalytic activity (GO:0050790) | 1.97 | 3 | PPT1, CLN3, SMPD1 |
biosynthetic process (GO:0009058) | 1.32 | 3 | PPT1, CLN8, SMPD1 |
associative learning (GO:0008306) | 5.44 | 3 | PPT1, CLN8, CLN3 |
regulation of proteolysis (GO:0030162) | 3.2 | 3 | CLN8, CLN3, CLN6 |
neurotransmitter transport (GO:0006836) | 5.07 | 3 | CLN8, PPT1, DNAJC5 |
regulation of neuron death (GO:1901214) | 4.19 | 3 | DNAJC5, PPT1, CLN3 |
negative regulation of neuron death (GO:1901215) | 4.57 | 3 | DNAJC5, PPT1, CLN3 |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 3 | CLN8, CLN3, SMPD1 |
endocytosis (GO:0006897) | 3.69 | 3 | PPT1, CLN3, GRN |
organonitrogen compound catabolic process (GO:1901565) | 3.91 | 3 | TPP1, PPT1, SMPD1 |
membrane organization (GO:0061024) | 3.04 | 3 | PPT1, CLN8, CLN3 |
single-organism behavior (GO:0044708) | 3.79 | 3 | PPT1, CLN8, CLN3 |
carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 3 | CLN6, SMPD1, CLN3 |
receptor-mediated endocytosis (GO:0006898) | 4.31 | 3 | PPT1, CLN3, GRN |
cognition (GO:0050890) | 4.2 | 3 | PPT1, CLN8, CLN3 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | CLN8, CLN3, SMPD1 |
phosphorus metabolic process (GO:0006793) | 2.15 | 3 | CLN8, SMPD1, CLN3 |
organophosphate metabolic process (GO:0019637) | 3.04 | 3 | CLN8, SMPD1, CLN3 |
signal release from synapse (GO:0099643) | 5.16 | 2 | DNAJC5, PPT1 |
steroid metabolic process (GO:0008202) | 4.32 | 2 | CLN8, CLN6 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | SMPD1, CLN6 |
sphingolipid catabolic process (GO:0030149) | 6.64 | 2 | PPT1, SMPD1 |
vesicle localization (GO:0051648) | 4.85 | 2 | DNAJC5, CLN3 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | SMPD1, CLN6 |
(GO:0099003) | 5.51 | 2 | DNAJC5, GRN |
negative regulation of proteolysis (GO:0045861) | 3.98 | 2 | CLN8, CLN3 |
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 5.19 | 2 | CTSF, CTSD |
regulation of cellular component organization (GO:0051128) | 2.01 | 2 | PPT1, GRN |
protein processing (GO:0016485) | 4.62 | 2 | CLN5, CLN3 |
anion transport (GO:0006820) | 3.71 | 2 | CLN8, CLN3 |
antigen processing and presentation of peptide antigen (GO:0048002) | 4.56 | 2 | CTSF, CTSD |
cellular lipid catabolic process (GO:0044242) | 4.73 | 2 | PPT1, SMPD1 |
establishment of organelle localization (GO:0051656) | 4.15 | 2 | DNAJC5, CLN3 |
establishment of vesicle localization (GO:0051650) | 4.91 | 2 | DNAJC5, CLN3 |
response to organic cyclic compound (GO:0014070) | 3.07 | 2 | SMPD1, GRN |
immune system process (GO:0002376) | 2.29 | 2 | CTSF, CTSD |
cholesterol metabolic process (GO:0008203) | 5.03 | 2 | CLN8, CLN6 |
single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | CLN8, SMPD1 |
negative regulation of catalytic activity (GO:0043086) | 3.0 | 2 | CLN3, SMPD1 |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | SMPD1, CLN6 |
ammonium ion metabolic process (GO:0097164) | 5.26 | 2 | SMPD1, CLN3 |
positive regulation of protein metabolic process (GO:0051247) | 2.43 | 2 | SMPD1, CLN6 |
amide biosynthetic process (GO:0043604) | 3.6 | 2 | CLN8, SMPD1 |
adult locomotory behavior (GO:0008344) | 5.3 | 2 | PPT1, CLN8 |
nitrogen compound transport (GO:0071705) | 3.54 | 2 | CLN8, CLN3 |
animal organ development (GO:0048513) | 2.53 | 2 | PPT1, CLN5 |
positive regulation of cellular protein metabolic process (GO:0032270) | 2.49 | 2 | SMPD1, CLN6 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | CLN8, CLN6 |
sphingomyelin metabolic process (GO:0006684) | 7.16 | 2 | SMPD1, CLN3 |
negative regulation of molecular function (GO:0044092) | 2.74 | 2 | SMPD1, CLN3 |
membrane lipid catabolic process (GO:0046466) | 6.51 | 2 | PPT1, SMPD1 |
antigen processing and presentation of exogenous peptide antigen (GO:0002478) | 4.63 | 2 | CTSF, CTSD |
lipid biosynthetic process (GO:0008610) | 3.49 | 2 | CLN8, SMPD1 |
carboxylic acid transport (GO:0046942) | 4.28 | 2 | CLN8, CLN3 |
autophagy (GO:0006914) | 3.82 | 2 | CLN3, CTSD |
sphingolipid biosynthetic process (GO:0030148) | 5.38 | 2 | CLN8, SMPD1 |
locomotory behavior (GO:0007626) | 4.53 | 2 | PPT1, CLN8 |
antigen processing and presentation (GO:0019882) | 4.36 | 2 | CTSF, CTSD |
sterol metabolic process (GO:0016125) | 4.92 | 2 | CLN8, CLN6 |
antigen processing and presentation of exogenous antigen (GO:0019884) | 4.59 | 2 | CTSF, CTSD |
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 5.21 | 2 | CTSF, CTSD |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504) | 5.14 | 2 | CTSF, CTSD |
amino acid transport (GO:0006865) | 5.29 | 2 | CLN8, CLN3 |
ion transport (GO:0006811) | 2.66 | 2 | CLN8, CLN3 |
organic anion transport (GO:0015711) | 4.07 | 2 | CLN8, CLN3 |
signal release (GO:0023061) | 4.65 | 2 | PPT1, DNAJC5 |
single-organism developmental process (GO:0044767) | 1.49 | 2 | PPT1, CLN5 |
secondary alcohol metabolic process (GO:1902652) | 5.0 | 2 | CLN8, CLN6 |
response to stress (GO:0006950) | 1.8 | 2 | TPP1, CLN8 |
single-organism membrane organization (GO:0044802) | 3.19 | 2 | PPT1, CLN8 |
neurotransmitter secretion (GO:0007269) | 5.7 | 2 | PPT1, DNAJC5 |
membrane lipid biosynthetic process (GO:0046467) | 4.99 | 2 | CLN8, SMPD1 |
cellular protein catabolic process (GO:0044257) | 6.51 | 2 | PPT1, CLN8 |
response to chemical (GO:0042221) | 1.98 | 2 | SMPD1, GRN |
response to organic substance (GO:0010033) | 2.2 | 2 | SMPD1, GRN |
organelle localization (GO:0051640) | 3.94 | 2 | DNAJC5, CLN3 |
cellular localization (GO:0051641) | 2.32 | 2 | DNAJC5, CLN3 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | SMPD1, GRN |
adult behavior (GO:0030534) | 4.79 | 2 | PPT1, CLN8 |
secretion (GO:0046903) | 3.38 | 2 | PPT1, DNAJC5 |
single-organism cellular localization (GO:1902580) | 3.16 | 2 | DNAJC5, CLN3 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | CLN8, SMPD1 |
brain development (GO:0007420) | 4.24 | 2 | PPT1, CLN5 |
organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 2 | CLN8, SMPD1 |
secretion by cell (GO:0032940) | 3.59 | 2 | DNAJC5, PPT1 |
lipid catabolic process (GO:0016042) | 4.21 | 2 | PPT1, SMPD1 |
alcohol metabolic process (GO:0006066) | 4.2 | 2 | CLN8, CLN6 |
single-organism organelle organization (GO:1902589) | 2.68 | 2 | CLN8, CLN3 |
presynaptic process involved in chemical synaptic transmission (GO:0099531) | 4.98 | 2 | DNAJC5, PPT1 |
peptide metabolic process (GO:0006518) | 3.44 | 2 | TPP1, CLN5 |
protein maturation (GO:0051604) | 4.48 | 2 | CLN5, CLN3 |
positive regulation of cellular component organization (GO:0051130) | 2.68 | 2 | PPT1, GRN |
ceramide biosynthetic process (GO:0046513) | 5.94 | 2 | CLN8, SMPD1 |
organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 2 | CLN8, CLN6 |